|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.110 CNY | -0.65% |
|
-3.70% | -9.80% |
| Capitalization | 1.22TCr 179.64Cr 154.47Cr 141.41Cr 133.6Cr 246.88Cr 17TCr 250.84Cr 1.68TCr 655.97Cr 8.19TCr 674.1Cr 659.85Cr 29TCr | P/E ratio 2024 |
14.8x | P/E ratio 2025 | 14.4x |
|---|---|---|---|---|---|
| Enterprise value | 519.96Cr 76Cr 66Cr 60Cr 57Cr 105.06Cr 7.38TCr 106.75Cr 713.41Cr 279.16Cr 3.49TCr 286.87Cr 280.81Cr 12TCr | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.7x |
| Free-Float |
39.6% | Yield 2024 |
2.51% | Yield 2025 | 2.97% |
| 1 day | -0.65% | ||
| 1 week | -3.70% | ||
| Current month | -5.01% | ||
| 1 month | -6.37% | ||
| 3 months | -14.30% | ||
| 6 months | -12.49% | ||
| Current year | -9.80% |
| 1 week | 9.04 |  | 9.4 |
| 1 month | 9.04 | | 9.78 |
| Current year | 9.04 | | 11.09 |
| 1 year | 9.04 | | 11.8 |
| 3 years | 7.61 | | 14.41 |
| 5 years | 7.61 | | 14.41 |
| 10 years | 7.61 | | 18.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Qian Yin Jing
IRC | Investor Relations Contact | 46 | 13/09/2019 |
Zhong Xi Zhang
SEC | Corporate Secretary | 50 | 28/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Xiang Dong Yu
BRD | Director/Board Member | 62 | 31/01/2019 |
Peng Wang
BRD | Director/Board Member | 44 | 28/11/2022 |
Yong Liu
BRD | Director/Board Member | 57 | 17/05/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.65% | -3.70% | -13.65% | -26.71% | 180.82Cr | |
| +2.97% | +4.68% | +7.35% | -23.90% | 6.21TCr | |
| -1.36% | -1.34% | +26.61% | +95.09% | 818.19Cr | |
| +0.93% | +1.80% | +10.22% | -10.81% | 783.87Cr | |
| +3.96% | -4.64% | +6.05% | +33.05% | 476.06Cr | |
| +3.19% | -0.71% | -20.28% | +53.04% | 404.37Cr | |
| +1.74% | -3.03% | -0.38% | -26.20% | 302.05Cr | |
| +0.04% | -4.90% | +49.22% | +41.05% | 282.6Cr | |
| +0.75% | -3.29% | +16.96% | -9.81% | 236.99Cr | |
| -0.69% | -7.12% | +64.12% | +23.96% | 188.99Cr | |
| Average | +1.11% | -2.01% | +14.62% | +14.88% | 988.04Cr | |
| Weighted average by Cap. | +2.30% | +0.09% | +9.87% | -4.13% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.09TCr 160.81Cr 138.28Cr 126.58Cr 119.6Cr 221Cr 16TCr 224.55Cr 1.5TCr 587.22Cr 7.33TCr 603.45Cr 590.7Cr 26TCr | 936.31Cr 137.66Cr 118.37Cr 108.36Cr 102.38Cr 189.19Cr 13TCr 192.23Cr 1.28TCr 502.69Cr 6.28TCr 516.58Cr 505.67Cr 22TCr |
| Net income | 108.36Cr 16Cr 14Cr 13Cr 12Cr 22Cr 1.54TCr 22Cr 148.68Cr 58Cr 726.41Cr 60Cr 59Cr 2.53TCr | 94Cr 14Cr 12Cr 11Cr 10Cr 19Cr 1.34TCr 19Cr 129.19Cr 51Cr 631.21Cr 52Cr 51Cr 2.2TCr |
| Net Debt | -650.52Cr -96Cr -82Cr -75Cr -71Cr -131.44Cr -9.24TCr -133.55Cr -892.54Cr -349.25Cr -4.36TCr -358.9Cr -351.32Cr -15TCr | -701.85Cr -103.19Cr -89Cr -81Cr -77Cr -141.82Cr -9.97TCr -144.09Cr -962.97Cr -376.81Cr -4.7TCr -387.23Cr -379.04Cr -16TCr |
Employees
9,697
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | 9.110 ¥ | -0.65% | 50,15,697 |
| 20/26/20 | 9.170 ¥ | -0.33% | 37,19,605 |
| 19/26/19 | 9.200 ¥ | +0.77% | 39,31,591 |
| 18/26/18 | 9.130 ¥ | -1.40% | 85,92,066 |
| 15/26/15 | 9.260 ¥ | -1.49% | 83,81,185 |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 600420 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition